Cowboys visit Eagles on Monday Night Football

The Dallas Cowboys visit the Philadelphia Eagles on Monday Night Football at Lincoln Financial Field in an NFC East clash featuring two struggling 2-4 teams. Kickoff is scheduled for 8:15 p.m. ET, with Dallas entering as 4.5-point road favorites and an over/under set at 43.5 points.

Tanner McKee Starts as Dallas Struggles on Defense

  • The Total: Advanced computer models project an Under outcome, noting that the under has hit in four of the last five meetings between the franchises.
  • Quarterback Shifts: Philadelphia turns once again to backup Tanner McKee under center following Jalen Hurts’ placement on injured reserve, directly impacting wide receiver ceilings.
  • Red Zone Efficiency: Dallas struggles heavily on defense, permitting opponents to convert 54.7% on third downs while Philadelphia converts 68.8% inside the red zone.

NFC East Struggles Meet Under the Lights

Both franchises arrive at this Week 7 divisional showdown looking to reverse a downward trajectory. cbssports.com reported that Dallas is coming off a 23-13 loss at Green Bay, whereas Philadelphia dropped a 25-14 decision to Carolina in Week 6. The Cowboys hold a 75-59 edge in the all-time series, though the Eagles have captured three of the last four matchups.

The visitor’s defense presents a glaring vulnerability. Squawka reported that Dallas concedes an opponent passer rating of 110.2 and allows opponents to convert 54.7% on third down, which ranks as the worst rate across the NFL. Meanwhile, the Cowboys offense generates 267.2 passing yards per game against an Eagles secondary allowing 244.5 yards through the air.

Rich Eisen on What’s at Stake for the 2-4 Cowboys & the 2-4 Eagles on Monday Night Football in WK7

Personnel Shortages Shape the Blueprint

Philadelphia’s roster depth faces a severe test without key starters. Squawka reported that the Eagles placed quarterback Jalen Hurts on injured reserve on October 17, followed by running back Will Shipley on October 16. In addition, wide receiver DeVonta Smith remains out with a hamstring injury, and running back Saquon Barkley is listed as questionable.

With Tanner McKee operating the offense, the unit looks to improve upon a scoring average of 17.7 points per game, which ties for 28th in the league. McKee completed 26 of 45 passes for 215 yards and one touchdown during the Week 6 loss to Carolina.

Team Record Last Game Result Key Absence
Dallas Cowboys 2-4 Lost 23-13 at Green Bay Injured Reserve List
Philadelphia Eagles 2-4 Lost 25-14 vs. Carolina Jalen Hurts (QB)

Advanced Modeling Points Toward Low-Scoring Affair

Advanced computer simulations project a tightly contested battle where scoring remains at a premium. cbssports.com noted that the model simulates the matchup 10,000 times, forecasting a total of 43 combined points and taking the Under at a 51% clip. Squawka’s model similarly evaluates the market, identifying value on the Eagles against a 4.5-point spread based on a projected 3-point margin.

Dak Prescott seeks to rebound after a difficult outing against Green Bay where he completed 34 of 54 passes for 258 yards, one touchdown, and two interceptions. The quarterback has accumulated 1,639 passing yards through six games, while Philadelphia’s defense has surrendered 1,467 passing yards and recorded 16 sacks over the same stretch.

Week 6 NFL odds, picks, predictions: Computer model backs Patriots and Cardinals
Photo: newsbreak.com

Monday night’s contest will dictate which historical rival stabilizes its season before the autumn schedule deepens into the winter push.

Disclaimer: The fantasy and market insights provided are for informational and entertainment purposes only and do not constitute financial or betting advice.

Cowboys vs Eagles: What to expect from the Monday Night showdown without Jalen Hurts and others
Photo of author

Luis Mendoza - Sport Editor

Senior Editor, Sport Luis is a respected sports journalist with several national writing awards. He covers major leagues, global tournaments, and athlete profiles, blending analysis with captivating storytelling.

GDFATHER-NEO Trial Design: Neoadjuvant Nivolumab with or without Visugromab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer